Pfizer, Inc. vs Waters Corporation — Stock Comparison
Pfizer, Inc. (PFE) and Waters Corporation (WAT) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Waters Corporation narrowly edges Pfizer, Inc. on Q·Score (6.9 vs 6.2 out of 10), led by Growth (7.7 vs 5.1) and Health (9.1 vs 7). Pfizer, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst price targets imply similar upside for both: +12.6% for PFE and +12.1% for WAT.
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
PFE vs WAT: which stock scores better overall?
Based on Q·Score, Waters Corporation (WAT) scores 6.9/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: PFE or WAT?
Waters Corporation (WAT) scores higher on Growth (7.7/10 vs 5.1/10). Pfizer, Inc. reports revenue growth (5.4% YoY) while Waters Corporation reports (91.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is PFE or WAT more attractively valued?
Waters Corporation (WAT) scores higher on Valuation (7.5/10 vs 7/10). PFE trades at 9.2× P/E versus WAT at 21.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about PFE vs WAT?
There are 27 analysts covering PFE with a consensus price target of $29.19, and 22 analysts covering WAT with a consensus target of $400.27. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: PFE or WAT?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 4/10). Net profit margin: PFE at 11.8%, WAT at 11.9%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: PFE or WAT?
Waters Corporation (WAT) scores higher on Financial Health (9.1/10 vs 7/10). Market beta: PFE at 0.29, WAT at 1.20. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of PFE and WAT?
Pfizer, Inc. (PFE) has a market capitalisation of $147.7B, while Waters Corporation (WAT) has a market cap of $35.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do PFE or WAT pay dividends?
PFE pays a dividend yield of 6.61%, while WAT does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →